GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Autonomix Medical Inc (NAS:AMIX) » Definitions » EV-to-EBIT

Autonomix Medical (Autonomix Medical) EV-to-EBIT : (As of May. 09, 2024)


View and export this data going back to 2024. Start your Free Trial

What is Autonomix Medical EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Autonomix Medical's Enterprise Value is $57.80 Mil. Autonomix Medical does not have enough years/quarters to calculate its EBIT for the trailing twelve months (TTM) ended in Dec. 2023. Therefore, GuruFocus does not calculate Autonomix Medical's EV-to-EBIT at this moment.

The historical rank and industry rank for Autonomix Medical's EV-to-EBIT or its related term are showing as below:

AMIX' s EV-to-EBIT Range Over the Past 10 Years
Min: -27.87   Med: 0   Max: 0
Current: -18.77

AMIX's EV-to-EBIT is ranked worse than
100% of 458 companies
in the Medical Devices & Instruments industry
Industry Median: 20.495 vs AMIX: -18.77

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Autonomix Medical's Enterprise Value for the quarter that ended in Dec. 2023 was $0.00 Mil. Autonomix Medical does not have enough years/quarters to calculate its EBIT for the trailing twelve months (TTM) ended in Dec. 2023. Therefore, GuruFocus does not calculate Autonomix Medical's Earnings Yield (Joel Greenblatt) % at this moment.


Autonomix Medical EV-to-EBIT Historical Data

The historical data trend for Autonomix Medical's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Autonomix Medical EV-to-EBIT Chart

Autonomix Medical Annual Data
Trend
EV-to-EBIT

Autonomix Medical Quarterly Data
Dec22 Dec23
EV-to-EBIT - -

Competitive Comparison of Autonomix Medical's EV-to-EBIT

For the Medical Devices subindustry, Autonomix Medical's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Autonomix Medical's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Autonomix Medical's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Autonomix Medical's EV-to-EBIT falls into.



Autonomix Medical EV-to-EBIT Calculation

Autonomix Medical's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=57.801/
=


Autonomix Medical  (NAS:AMIX) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Autonomix Medical's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=/0
= %


Autonomix Medical EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Autonomix Medical's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Autonomix Medical (Autonomix Medical) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Website
Autonomix Medical Inc is a development stage medical device development company focused on advancing innovative technologies for sensing and treating disorders relating to the nervous system. Its first-in-class technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies.